Uti Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 27-01-2026
NAV ₹268.98(R) -0.07% ₹304.85(D) -0.06%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 1.82% 22.67% 14.1% 18.25% 11.49%
Direct 2.84% 23.88% 15.29% 19.45% 12.61%
Nifty Pharma TRI 3.06% 21.22% 12.59% 14.93% 7.47%
SIP (XIRR) Regular -6.33% 13.63% 14.57% 16.76% 15.08%
Direct -5.38% 14.83% 15.75% 17.98% 16.22%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.12 0.62 0.96 4.35% 0.2
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.66% -16.02% -15.36% 0.87 10.72%
Fund AUM As on: 30/12/2025 1118 Cr

No data available

NAV Date: 27-01-2026

Scheme Name NAV Rupee Change Percent Change
UTI Healthcare Fund - Regular Plan - IDCW 207.89
-0.1500
-0.0700%
UTI Healthcare Fund - Direct Plan - IDCW 235.63
-0.1500
-0.0600%
UTI Healthcare Fund - Regular Plan - Growth Option 268.98
-0.2000
-0.0700%
UTI Healthcare Fund - Direct Plan - Growth Option 304.85
-0.1900
-0.0600%

Review Date: 27-01-2026

Beginning of Analysis

The Uti Healthcare Fund has shown an excellent past performence in Pharma Fund. The Uti Healthcare Fund has a Jensen Alpha of 4.35% which is higher than the category average of 3.25%. Here the Uti Healthcare Fund has shown good performance in terms of risk adjusted returns. The Uti Healthcare Fund has a Sharpe Ratio of 1.12 which is higher than the category average of 1.08. Here the Uti Healthcare Fund has shown good performance in terms of risk adjusted returns.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

Uti Healthcare Fund Return Analysis

The Uti Healthcare Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of -4.63%, -7.5 and -8.87 in last one, three and six months respectively. In the same period the category average return was -4.54%, -6.79% and -7.61% respectively.
  • Uti Healthcare Fund has given a return of 2.84% in last one year. In the same period the Nifty Pharma TRI return was 3.06%. The fund has given 0.22% less return than the benchmark return.
  • The fund has given a return of 23.88% in last three years and rank 2nd out of eight funds in the category. In the same period the Nifty Pharma TRI return was 21.22%. The fund has given 2.66% more return than the benchmark return.
  • Uti Healthcare Fund has given a return of 15.29% in last five years and category average returns is 15.86% in same period. The fund ranked 6.0th out of eight funds in the category. In the same period the Nifty Pharma TRI return was 12.59%. The fund has given 2.7% more return than the benchmark return.
  • The fund has given a return of 12.61% in last ten years and ranked 3.0rd out of four funds in the category. In the same period the Nifty Pharma TRI return was 7.47%. The fund has given 5.14% more return than the benchmark return.
  • The fund has given a SIP return of -5.38% in last one year whereas category average SIP return is -5.84%. The fund one year return rank in the category is 8th in 13 funds
  • The fund has SIP return of 14.83% in last three years and ranks 2nd in 8 funds. Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has given the highest SIP return (17.05%) in the category in last three years.
  • The fund has SIP return of 15.75% in last five years whereas category average SIP return is 15.61%.

Uti Healthcare Fund Risk Analysis

  • The fund has a standard deviation of 15.66 and semi deviation of 10.72. The category average standard deviation is 15.33 and semi deviation is 10.66.
  • The fund has a Value at Risk (VaR) of -16.02 and a maximum drawdown of -15.36. The category average VaR is -16.12 and the maximum drawdown is -14.76. The fund has a beta of 0.88 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -4.70 -3.50
    -4.63
    		-6.50 | -3.37 8 | 13 Good
    3M Return % -7.73 -2.32
    -7.09
    		-9.39 | -4.89 11 | 13 Average
    6M Return % -9.30 -4.19
    -8.20
    		-9.74 | -6.55 12 | 13 Average
    1Y Return % 1.82 3.06
    0.36
    		-4.58 | 6.46 5 | 13 Good
    3Y Return % 22.67 21.22
    21.55
    		19.92 | 25.68 2 | 8 Very Good
    5Y Return % 14.10 12.59
    14.47
    		12.81 | 16.53 6 | 8 Average
    7Y Return % 18.25 14.93
    19.47
    		18.25 | 21.18 7 | 7 Poor
    10Y Return % 11.49 7.47
    11.79
    		11.08 | 13.37 2 | 4 Good
    15Y Return % 13.54 11.54
    15.05
    		13.54 | 15.93 3 | 3 Average
    1Y SIP Return % -6.33
    -7.08
    		-19.64 | -0.83 7 | 13 Good
    3Y SIP Return % 13.63
    12.22
    		8.18 | 16.00 2 | 8 Very Good
    5Y SIP Return % 14.57
    14.21
    		12.92 | 17.19 3 | 8 Good
    7Y SIP Return % 16.76
    17.26
    		16.21 | 19.41 5 | 7 Average
    10Y SIP Return % 15.08
    15.48
    		15.08 | 16.03 4 | 4 Poor
    15Y SIP Return % 14.03
    15.10
    		14.03 | 15.87 3 | 3 Average
    Standard Deviation 15.66
    15.33
    		14.13 | 16.15 5 | 8 Average
    Semi Deviation 10.72
    10.66
    		9.75 | 11.19 4 | 8 Good
    Max Drawdown % -15.36
    -14.76
    		-16.36 | -12.33 5 | 8 Average
    VaR 1 Y % -16.02
    -16.12
    		-19.03 | -13.05 4 | 8 Good
    Average Drawdown % -4.22
    -4.98
    		-6.39 | -3.87 2 | 8 Very Good
    Sharpe Ratio 1.12
    1.08
    		0.95 | 1.35 3 | 8 Good
    Sterling Ratio 0.96
    0.94
    		0.85 | 1.07 3 | 8 Good
    Sortino Ratio 0.62
    0.58
    		0.51 | 0.70 3 | 8 Good
    Jensen Alpha % 4.35
    3.25
    		0.58 | 7.60 3 | 8 Good
    Treynor Ratio 0.20
    0.19
    		0.16 | 0.24 3 | 8 Good
    Modigliani Square Measure % 25.65
    25.01
    		22.41 | 29.62 3 | 8 Good
    Alpha % 1.11
    0.03
    		-2.19 | 4.93 2 | 8 Very Good
    Return data last Updated On : Jan. 27, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2025
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -4.63 -3.50 -4.54 -6.41 | -3.26 9 | 13 Average
    3M Return % -7.50 -2.32 -6.79 -9.11 | -4.62 11 | 13 Average
    6M Return % -8.87 -4.19 -7.61 -9.18 | -5.91 12 | 13 Average
    1Y Return % 2.84 3.06 1.66 -3.02 | 7.72 5 | 13 Good
    3Y Return % 23.88 21.22 22.98 21.53 | 26.75 2 | 8 Very Good
    5Y Return % 15.29 12.59 15.86 14.41 | 17.55 6 | 8 Average
    7Y Return % 19.45 14.93 20.92 19.45 | 22.47 7 | 7 Poor
    10Y Return % 12.61 7.47 13.07 12.31 | 14.39 3 | 4 Average
    1Y SIP Return % -5.38 -5.84 -18.45 | 0.37 8 | 13 Good
    3Y SIP Return % 14.83 13.64 9.78 | 17.05 2 | 8 Very Good
    5Y SIP Return % 15.75 15.61 14.52 | 18.22 3 | 8 Good
    7Y SIP Return % 17.98 18.71 17.57 | 20.53 6 | 7 Average
    10Y SIP Return % 16.22 16.77 16.22 | 17.07 4 | 4 Poor
    Standard Deviation 15.66 15.33 14.13 | 16.15 5 | 8 Average
    Semi Deviation 10.72 10.66 9.75 | 11.19 4 | 8 Good
    Max Drawdown % -15.36 -14.76 -16.36 | -12.33 5 | 8 Average
    VaR 1 Y % -16.02 -16.12 -19.03 | -13.05 4 | 8 Good
    Average Drawdown % -4.22 -4.98 -6.39 | -3.87 2 | 8 Very Good
    Sharpe Ratio 1.12 1.08 0.95 | 1.35 3 | 8 Good
    Sterling Ratio 0.96 0.94 0.85 | 1.07 3 | 8 Good
    Sortino Ratio 0.62 0.58 0.51 | 0.70 3 | 8 Good
    Jensen Alpha % 4.35 3.25 0.58 | 7.60 3 | 8 Good
    Treynor Ratio 0.20 0.19 0.16 | 0.24 3 | 8 Good
    Modigliani Square Measure % 25.65 25.01 22.41 | 29.62 3 | 8 Good
    Alpha % 1.11 0.03 -2.19 | 4.93 2 | 8 Very Good
    Return data last Updated On : Jan. 27, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2025
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Uti Healthcare Fund NAV Regular Growth Uti Healthcare Fund NAV Direct Growth
    27-01-2026 268.9826 304.8535
    23-01-2026 269.1792 305.0436
    22-01-2026 272.0199 308.2545
    21-01-2026 269.3055 305.1703
    20-01-2026 270.4107 306.4146
    19-01-2026 275.6611 312.3556
    16-01-2026 277.5921 314.5183
    14-01-2026 280.6122 317.9231
    13-01-2026 280.93 318.2746
    12-01-2026 280.6272 317.923
    09-01-2026 282.0208 319.4761
    08-01-2026 285.5948 323.5161
    07-01-2026 289.6057 328.0507
    06-01-2026 288.3786 326.652
    05-01-2026 286.8959 324.9637
    02-01-2026 286.9493 324.9981
    01-01-2026 284.6919 322.4326
    31-12-2025 283.964 321.5996
    30-12-2025 281.1774 318.4351
    29-12-2025 282.2591 319.6516

    Fund Launch Date: 27/May/1999
    Fund Category: Pharma Fund
    Investment Objective: The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equities and equity related securities of companies/ institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
    Fund Description: An open ended equity scheme investing in the Healthcare Services Sector
    Fund Benchmark: S&P BSE Healthcare
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.